Impact of diet on the efficacy of insulin lispro mix 25 and insulin lispro mix 50 as starter insulin in East Asian patients with type 2 diabetes: Subgroup analysis of the Comparison Between Low Mixed Insulin and Mid Mixed Insulin as Starter Insulin For Patients with Type 2 Diabetes Mellitus (CLASSIFY Study) randomized trial

What Was Tested

Researchers studied Insulin Lispro in this randomized controlled trial publication.

The pathophysiology of diabetes differs between Asian and Western patients in many ways, and diet is a primary contributor.

Who Took Part

By PubMed's age tags, the people studied were middle-aged adults, both men and women.

Nutritional intake was assessed from food records kept by participants before study drug administration.

How the Study Was Run

The researchers set it up as a randomized, open-label and parallel-group study.

Random assignment meant chance, not the researchers, decided who got Insulin Lispro and who got the comparison, which limits bias.

Everyone knew when Insulin Lispro was being given (open label), which is simpler to run but leaves more room for expectations to affect what is reported.

The Insulin Lispro group and the comparison group ran side by side rather than switching.

This was a predefined subgroup analysis of a phase 4, open-label, 26-week, parallel-arm, randomized (computer-generated random sequence) trial (21 January 2013 to 22 August 2014).

Outcomes assessed were changes from baseline in self-monitored blood glucose, 1,5-anhydroglucitol and glycated hemoglobin.

What Was Measured

Topics PubMed links to this paper include Asian People, Diabetes Mellitus, Type 2, Diet, Drug Combinations, Hypoglycemic Agents, Insulin Lispro and Nutrition Assessment.

What This Means in Plain Language

The paper is a randomized, open-label and parallel-group study of Insulin Lispro.

Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2017 (Journal of diabetes investigation), a journal based in Japan.

More context: the Insulin Lispro compound page, all human trials.